MANE
Veradermics, Inc
NYSE · Healthcare · Biotechnology · US
$143.85
+0.01%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-11.4%
Return on equity
-11.2%
Return on assets
-12.6%
Return on invested capital
0.00x
Asset turnover
-$78.3M
Cash from operations
$20
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026